Nucleus Software Approves New RSU Scheme 2026, Terminates Old ESOP Scheme
Nucleus Software approved the termination of its ESOP Scheme 2015 and established the Nucleus Software RSU Scheme 2026. The new scheme includes a pool of 10,00,000 RSUs. The company also approved the formation of the Nucleus Software Equity Incentive Trust.
The introduction of a new RSU scheme and the termination of an old ESOP scheme can impact employee motivation and future equity dilution, which are medium-term considerations for the company's stakeholders.
The announcement details the termination of an old ESOP scheme and the introduction of a new RSU scheme, which is a routine corporate action related to employee benefits and does not inherently indicate a positive or negative financial impact.
Nucleus Software Exports Limited announced the outcome of its Board Meeting held on March 25, 2026. The board approved the termination of the ESOP Scheme – 2015 and the dissolution of the Nucleus Software Employee Welfare Trust.
Furthermore, the company approved the Nucleus Software RSU Scheme – 2026. Under this new scheme, a pool of 10,00,000 Restricted Stock Units (RSUs) will be available, exercisable into an equal number of equity shares of face value ₹10 each. The scheme will be administered by the Nomination and Remuneration/Compensation Committee and implemented through an irrevocable trust, the Nucleus Software Equity Incentive Trust. The primary mode of acquisition for the trust will be through secondary acquisition from the market.
The board also approved the grant of RSUs to eligible employees of the company and its subsidiaries under the new RSU Scheme – 2026. The formation of the Nucleus Software Equity Incentive Trust was also approved, along with the provision of a loan by the company to this trust for the purchase of its own equity shares for employee benefits.
What to do with a filing like this
Nucleus Software Exports Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nucleus Software Exports Limited. Read the original for the full detail.